// App-Quantinova.ai

P151 : Refractory Hypoxemic Respiratory Failure Secondary to Hepatopulmonary Syndrome in a Pediatric Patient

Researchers

Presenter

  • A. Wannes Daou

Principal Investigators

  • A. Miethke

  • B. Mullapudi

  • A. T. Trout

  • K. L. Jennifer

  • C. Towe

Medical Centers

  • Pulmonary Medicine, Cincinnati Children's Hospital, Cincinnati, OH, United States

  • Pediatric General and Thoracic Surgery, Cincinnati Children's Hospital, Cincinnati, OH, United States

  • Pediatric Pulmonary, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States

  • Gastroenterology, Cincinnati Children's Hospital, Cincinnati, OH, United States

  • Radiology and Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Genetic Disorder

  • Gastroenterology (GU)

  • Pulmonary/Respiratory Diseases

Disease

  • Hepatopulmonary Syndrome

  • End-stage liver disease

  • Dyskeratosis congenita

  • Portal Hypertension

  • Hepatic fibrosis

  • Hypertension

  • Venous thrombosis

  • Anemia

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Case report

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved